Page last updated: 2024-11-11

cbs 211 a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

CBS 211 A: synthetic retinoic acid analog [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6436049
CHEMBL ID2107644
SCHEMBL ID1815139
SCHEMBL ID10464772
MeSH IDM0173656

Synonyms (24)

Synonym
namirotene
cbs-211a
p-((e)-2-(5-isopropyl-2-thienyl)propenyl)benzoic acid
(e)-4-(2-(5-(1-methylethyl)-2-thienyl)-1-propenyl)benzoic acid
namirotene [inn]
cbs 211a
cbs 211 a
(e)-4-(2-(2-isopropyl-5-thienyl)propenyl)benzoic acid
benzoic acid, 4-(2-(5-(1-methylethyl)-2-thienyl)-1-propenyl)-, (e)-
4-[(e)-2-(5-propan-2-ylthiophen-2-yl)prop-1-enyl]benzoic acid
unii-1fg8fgl0yi
4-(2-(2-isopropyl-5-thienyl)propenyl)benzoic acid
101506-83-6
1fg8fgl0yi ,
cbs-211 a
CHEMBL2107644
SCHEMBL1815139
SCHEMBL10464772
AKOS032945531
(e)-4-(2-(5-isopropylthiophen-2-yl)prop-1-en-1-yl)benzoic acid
Q27252362
(e)-4-(2-(5-isopropylthiophen-2-yl)prop-1-en-1-yl)benzoicacid
4-[(1e)-2-[5-(propan-2-yl)thiophen-2-yl]prop-1-en-1-yl]benzoic acid
F86381
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.94 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]